Skip to main content
UploadLanguage (EN)Support
BusinessMobileSocial MediaMarketingTechnologyArt & PhotosCareerDesignEducationPresentations & Public SpeakingGovernment & NonprofitHealthcareInternetLawLeadership & ManagementAutomotiveEngineeringSoftwareRecruiting & HRRetailSalesServicesScienceSmall Business & EntrepreneurshipFoodEnvironmentEconomy & FinanceData & AnalyticsInvestor RelationsSportsSpiritualNews & PoliticsTravelSelf ImprovementReal EstateEntertainment & HumorHealth & MedicineDevices & HardwareLifestyle
Chetan Mali, profile picture
Uploaded byChetan Mali
369 views

INDUSTRIAL PHARMACY II (BP702T) UNIT 2 (IP2)

This unit focuses on the systematic transfer of pharmaceutical manufacturing processes from research and development to commercial production. It covers technology transfer, scale-up, process validation, documentation, regulatory requirements, and quality risk management to ensure consistent product quality and successful manufacturing.

Education◦
➢ Technology Transfer • Technology Transfer is the systematic process of transferring knowledge, skills, manufacturing methods, analytical methods, and documentation from one unit (R&D/Pilot Plant) to another unit (Manufacturing Site) to ensure consistent and reproducible production of a product on a commercial scale. ✓ Objectives of Technology Transfer • To ensure smooth transfer of a laboratory-scale formulation to commercial production. • To maintain the quality, safety, and efficacy of the product during scale-up. • To provide all necessary documents, SOPs, training, and technical knowledge (know-how) to the receiving unit. • To ensure regulatory compliance with guidelines such as FDA, WHO, and EMA. • To minimize the risk of failures, deviations, and quality defects during manufacturing.
❑ WHO GUIDELINES FOR TECHNOLOGY TRANSFER (TT) • The World Health Organization (WHO) is a specialized agency of the United Nations (UN) for international public health. • It was established on 7 April 1948. • Its headquarters is in Geneva, Switzerland. • Technology is shifted from one site to another the quality, safety, efficacy of the product remain same. • Technology transfer is not just movement of documents but also involve the transfer of practical knowledge of skills.
1. Introduction • Technology Transfer is a logical and documented procedure to transfer knowledge, process, and documentation from one site (Sending Unit - SU) to another site (Receiving Unit - RU). • Goal: The Receiving Unit (RU) should be able to reproduce the product/process with the same quality as the Sending Unit (SU). • Requirements: • Planned approach • Trained staff • Proper documentation • Quality system
2. Scope of the WHO Guidelines The WHO guidelines mainly apply to: • The transfer of the manufacturing process, including production, packaging, and cleaning. • The transfer of analytical methods used in quality control. • The evaluation of premises and equipment to ensure they meet regulatory standards. • The organization and management of technology transfer, including: o Documentation o Training o Qualification o Validation
3. Organization And Management For a technology transfer to be successful, there must be a clear organizational structure: • A formal agreement is signed between the SU and RU, specifying responsibilities before, during, and after the transfer. • A project management plan is prepared, which includes the objectives, key personnel, roles, and the sequence of transfer activities. • The process is monitored through a transfer protocol, which records the steps, acceptance criteria, critical control points, and validation procedures. • A joint project team, consisting of experts from both SU and RU, manages the transfer. • Training plays a major role staff at the RU must be properly trained to handle new processes or analytical methods.
4. Production Transfer • RU must have capacity to handle production. • SU must provide detailed info on: o APIs & Excipients - source, specifications, solubility, stability, particle size, impurities etc. o Finished Products - formulation, process steps, in-process controls, packaging, safety requirements. • RU should compare facilities / equipment and resolve differences. • Packaging: Info on containers, labels, anti-counterfeit measures.. • Cleaning: SU provides cleaning procedures & validation; RU adapts them and validates again. • Trial batches produced at RU before scale-up validation.
5. Quality Control : Analytical Method Transfer • Analytical methods (assay, dissolution, impurities, microbiology, cleaning residues) must be transferred with proper documentation. • SU provides method training, validation reports, and reference standards. • RU ensures equipment readiness, trained staff, and performs re-validation. • Transfer considered successful if test results match SU test results within predefined limits.
6. Premises And Equipment • The environment and equipment used in manufacturing play a critical role in product quality. • The SU must provide detailed information about building layout, utilities, water systems, and waste management. • The SU should also share lists of equipment (with make, model, and qualification status). • The RU then compares its own facilities and equipment with those of the SU, performing a gap analysis to identify differences.
7. Documentation • WHO guidelines highlight that documentation is the backbone of technology transfer. Examples of required documents include: • Project plans, protocols, risk assessments, and gap analysis reports. • Validation and qualification protocols and reports. • Training documents and SOPs. • Analytical method transfer reports. • Cleaning validation records.
8. Qualification And Validation • Technology transfer is incomplete without proper qualification and validation. • WHO recommends using risk management principles to decide the extent of validation required. • Equipment qualification includes IQ (Installation Qualification), OQ (Operational Qualification), and PQ (Performance Qualification). • Process validation and cleaning validation must be performed at the RU to confirm that the transferred process consistently produces the desired results.
❑ TERMINOLOGY 1. Acceptance Criteria • Acceptance criteria are the measurable limits used to decide whether a test result is acceptable. 2. Bracketing • Bracketing is an experimental design in which only the extreme samples (e.g., highest and lowest dosage strengths) are tested. • It assumes that the results of the extremes represent all intermediate samples. 3. Change Control (CC) • Change Control is a formal system used to review any proposed or actual changes that may affect the validated status of a product or process. • It ensures that the validated state is maintained. 4. Critical • Critical means having the potential to significantly affect product quality or performance.
5. Critical Control Point (CCP) • A Critical Control Point (CCP) is a step in the process where control is necessary to prevent, eliminate, or reduce a quality risk to an acceptable level. 6. Corrective Action • Corrective Action is the action taken when monitoring at a Critical Control Point (CCP) shows that the process is not under control. 7. Quality Risk Management (QRM) • Quality Risk Management (QRM) is a systematic process for the assessment, control, communication, and review of risks that may affect the quality of a pharmaceutical product throughout its entire product life cycle. 8. Inter Company Transfer • Inter company transfer is the transfer of technology between two different companies.
9. Intra Company Transfer • Intra company transfer is the transfer of technology between sites belonging to the same group of companies. 10. Inter Site Transfer • Inter site transfer is the transfer of technology between different manufacturing sites of the same company. 11. In-Process Control (IPC) • In-Process Control (IPC) refers to the checks performed during manufacturing to monitor and, if necessary, adjust the process so that the product meets its specified quality standards. Monitoring of the manufacturing environment and equipment is also considered part of IPC. 12. Qualification • Qualification is the process of proving and documenting that a building, system, or equipment is properly installed, works correctly, and gives the expected results.
13. Installation Qualification (IQ) • IQ is the documented verification that machines, instruments, utilities, and manufacturing areas are properly selected, correctly installed, and meet the required specifications. 14. Operational Qualification (OQ) • OQ is the documented verification that the equipment or system operates properly within the specified operating range. 15. Performance Qualification (PQ) • PQ is the documented verification that the equipment consistently produces reproducible results according to predefined specifications during routine use. 16. Standard Operating Procedure (SOP) • An SOP is an authorized written procedure that provides step-by-step instructions for performing routine operations consistently and correctly.
17. Drug Master File (DMF) • A Drug Master File (DMF) is a confidential document that contains detailed information about a specific manufacturing facility, process, material, or product. It is submitted to the Drug Regulatory authority to support the application for marketing authorization (drug approval). 18. Technology Transfer Protocol • A Technology Transfer Protocol is a written document that describes the step-by-step plan for transferring a manufacturing process or technology from one site to another. It ensures the transfer is carried out systematically and successfully.
❑TECHNOLOGY TRANSFER PROTOCOLS • A Technology Transfer Protocol is a formal written plan that describes in detail how the transfer of a process, method, or product will be carried out from the Sending Unit (SU) to the Receiving Unit (RU). • It works like a roadmap - it ensures that every step of the transfer is performed in a systematic, documented, and controlled way. ➢ Contents Of A Technology Transfer Protocol 1. Objective • Clear statement of aim of the transfer (e.g., transfer of tablet manufacturing process). 2. Scope • Defines which product / process / method is being transferred and to which sites. 3. Key Personnel And Responsibilities • Names and roles of SU and RU staff involved. • Project manager and team responsibilities.
4. Materials, Methods And Equipment Comparison • A side-by-side comparison of equipment, raw materials, and methods at SU and RU. Identifies differences and possible risks (gap analysis). 5. Stages Of Transfer • Stepwise procedure of transfer, with documented evidence for each stage before moving to the next. 6. Critical Control Points • Identifies steps where process control is crucial to maintain product quality. 7. Experiment Design And Acceptance Criteria • Outlines how the RU will prove successful transfer (e.g., producing trial / validation batches). • Defines limits / criteria to judge success.
8. Production Batches • Details of trial batches, qualification batches, and validation batches to be made at the RU. 9. Change Control And Deviations • Plan for how any unexpected issues or process deviations will be handled. 10. End-product Assessment • Quality evaluation of the transferred product (testing, stability, comparison with SU batches). 11. Samples And References • Arrangements for retention samples, reference standards, and storage. 12. Training • Training plan for RU staff on product, process, and analytical methods. 13. Conclusions And Approval • Final section signed by SU, RU, and project manager to confirm completion of transfer.
❑ QUALITY RISK MANAGEMENT • It is a systematic process of identifying, assessing, and controlling risks to the quality of pharmaceutical products throughout their lifecycle to ensure patient safety and product efficacy. ▪ Quality: • Quality is a never-ending cycle of continuous improvement. ▪ Risk: • Risk is the combination of probability of occurrence of harm and the severity of that harm. ▪ Management: • Management is the systematic process for the assessment, control, communication, and review of risks.
➢ Principles Of QRM. The two main principles of Quality Risk Management (QRM) are: 1. Risk Evaluation is Based on Science • QRM decisions must be based on a scientific understanding of the process and a connection to patient safety. • The level of effort, formality, and documentation should be proportional to the level of risk. • A higher risk requires a more formal and detailed approach. 2. Protecting the Patient • The ultimate goal of QRM is to ensure product quality and, therefore, protect the patient from potential harm. • Risks that could affect the safety, efficacy, or quality of the drug are given the highest priority.
➢ QRM Process Step 1: Risk Assessment • Identify what can go wrong (define risk). • List potential hazards linked to the process or product. • Analyse and estimate the likelihood and consequences of each hazard. • Evaluate which risks are more severe and need action. Step 2: Risk Control • Decide what actions will reduce or eliminate unacceptable risks. • Implement controls and keep records of actions taken. • Monitor the effectiveness of the controls.
Step 3: Risk Communication • Share findings and decisions with all stakeholders, such as production, quality, and regulatory teams. Step 4: Risk Review • Continually review, update, and improve the QRM process. • Reassess risks as new data emerge, especially after technology transfer or process changes.
❑ TECHNOLOGY TRANSFER (TT) FROM R&D TO PRODUCTION • Technology Transfer (TT) from R&D to Production means moving the knowledge and practices developed during research into a commercial manufacturing site in such a way that the product can be consistently produced on a large scale with the same quality, safety, and efficacy. 1. Process Transfer • Process Transfer involves moving the complete manufacturing process (formulation, mixing, granulation, drying, coating, etc.) developed in R&D to the production site. ✓ Steps Involved • Preparation and review of process protocols. • Identification of Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs). • Conducting pilot batches for process standardization. • Scale-up of the manufacturing process from laboratory to production level. • Documentation of all process steps.
2. Packaging Transfer • Packaging Transfer refers to replicating R&D packaging methods for commercial production while maintaining product integrity, stability, and regulatory standards. ✓ Steps Involved • Selection of suitable packaging materials. • Validation of the packaging process. • Standardization of labelling and sealing process. • Assessment of packaging compatibility with the product.
3. Cleaning Transfer • Cleaning Transfer refers to transferring cleaning procedures developed in R&D, including the selection of cleaning agents and methods. Steps Involved • Validation of cleaning methods on production equipment. • Establishment of acceptance criteria for equipment cleanliness. • Documentation of cleaning processes.
4. Documentation and Communication • All procedures, results, and verifications should be well documented. • Ensure coordination between R&D, Production, Quality Control (QC), and Quality Assurance (QA) teams to facilitate a smooth and compliant technology transfer. Examples Include • Technology Transfer Protocol (TT Protocol) • Master Batch Records (MBR) • Packaging Instructions • Cleaning Validation Report • Training Records of Staff
❑ GRANULARITY OF TECHNOLOGY TRANSFER PROCESS • Granularity in Technology Transfer (TT) refers to the level of detail in which different elements of the product and process are transferred from R&D to Production. • It ensures that every aspect from raw materials to packaging is clearly defined, documented, and validated so that the commercial product maintains the same quality, safety, and efficacy as developed in R&D. 1. API (Active Pharmaceutical Ingredient) • The API is the core of the drug product; therefore, its transfer requires very fine granularity. ✓ Details Include: • Source and specifications: Supplier details, grade, purity profile. • Physicochemical properties: Solubility, stability, particle size distribution, polymorphism. • Synthesis/Manufacturing process: Steps, reagents, critical process parameters. • Analytical data: Methods for assay, impurities, and stability studies. • Storage and handling: Temperature, humidity conditions, and container type.
2. Excipients • Excipients affect the stability, bioavailability, and manufacturing of the product. ✓ Details Include: • Functional role: Diluent, binder, disintegrant, lubricant, coating agent, etc. • Compatibility data with API. • Source and specifications: Vendor qualification and pharmacopoeia compliance. • Analytical methods for identity and purity. • Storage conditions: e.g., moisture-sensitive excipients.
3. Finished Products • Finished products represent the final dosage form (tablet, capsule, injection, suspension, etc.). ✓ Details Include: • Formulation composition: Exact amounts of API and excipients. • Manufacturing process: Mixing speed, granulation endpoint, drying time/temperature, compression force, coating parameters. Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs). • Validation data: Pilot batches and scale-up results. • Stability studies: Long-term and accelerated. • Regulatory specifications: Dissolution profile and assay.
4. Packaging Materials • Packaging materials ensure product protection, stability, and patient safety during storage, transportation, and use. ✓ Details Include: • Primary Packaging: Blister materials (PVC, PVDC, Alu-Alu), bottles (HDPE, glass), vials, ampoules, closures, and seals. • Secondary Packaging: Cartons, labels, and package inserts/leaflets. • Specifications: Thickness, permeability, and compatibility with the product. • Packaging Process Parameters: Sealing temperature, machine speed, and capping torque. • Stability Studies: Shelf-life evaluation under different storage conditions.
❑ ANALYTICAL METHOD TRANSFER • Analytical Method Transfer is the process of passing an analytical testing procedure from one laboratory to another laboratory. • The goal is to make sure the receiving lab can perform the test exactly as the sending lab did, with reliable and equivalent results. ➢ Importance • When a method is developed in one lab (like R&D or a main Quality Control lab), it needs to be used in other labs for routine or regulatory reasons. • The transfer ensures consistency, accuracy, and reliability of results across different labs.
➢ Types Of Analytical Method Transfer 1. Comprative Testing • Both sending and receiving labs analyse the same samples. • Results are compared to check if the receiving lab gets equivalent data. • Most common and straight forward transfer type. 2. Co-validation • Both labs validate the method together during transfer. • Receiving lab participates in method validation experiments (e.g., precision). • Used often during transfer from R&D to manufacturing labs.
3. Revalidation • Receiving lab repeats some or all validation test (accuracy, precision, specificity) • Necessary if method changes or transfer involves significant updates. • Confirms method works correctly in the new lab. 4. Transfer Waiver • No formal transfer testing required. • Applicable for standard, well-established methods or if justified by previous knowledge. • Requires clear documentation explaining why waiver is allowed.
❑ Documentation • Documentation is the backbone of Technology Transfer (TT). • It ensures that all technical knowledge is clearly documented so that the receiving unit (production site) can reproduce the product exactly as developed in the R&D (sending unit). ➢ Main Documents in Technology Transfer (TT) 1. Technology Transfer Protocol (TTP) • Official agreement describing what will be transferred, timelines, and responsibilities. 2. Master Formula Record (MFR) • Stepwise recipe of the product including materials, quantities, and process parameters. 3. Batch Manufacturing Record (BMR) • Actual manufacturing execution document prepared at the receiving unit and compared with the MFR.
4. Analytical Methods Documentation • Validated analytical test methods transferred to the Quality Control (QC) laboratory. 5. Reports • Validation reports • Cleaning validation reports • Deviation reports
❑ Premises & Equipment • During Technology Transfer (TT), the receiving unit's premises and equipment must be assessed for suitability. 1. Premises • Layout should allow smooth material flow and prevent cross-contamination. • Adequate utilities (water system, HVAC, compressed air). • Cleanroom classification (for sterile products). 2. Equipment • Equipment must match (or be equivalent to) that used in R&D. • If not identical, comparability studies are required. • Cleaning procedures must be standardized and validated.
❑ Qualification & Validation • The receiving site must prove that its premises, utilities, and equipment are qualified before use. ➢ Qualification Steps 1. DQ (Design Qualification): Confirms design meets intended purpose. 2. IQ (Installation Qualification): Verifies correct installation. 3. OQ (Operational Qualification): Checks equipment operation. 4. PQ (Performance Qualification): Confirms consistent performance. ➢ Validation During Technology Transfer (TT) 1. Process Validation: New site runs validation batches to demonstrate consistent results. 2. Cleaning Validation: Ensures no cross-contamination when equipment is shared. 3. Analytical Method Validation: QC laboratory reproduces the same accuracy and precision as R&D.
❑ Quality Control (QC) • Quality Control (QC) plays a vital role in confirming that the transferred technology works properly. ➢ It Includes • Raw Material Testing: API and excipients at the receiving site. • In-process Control Checks: e.g., pH, granule size, weight variation. • Finished Product Testing: Assay, dissolution, sterility, etc. • Comparative Analysis: Product from the receiving site is compared with the product from the sending unit. • Stability Studies: Ensure the product remains stable under storage conditions.
❑TECHNOLOGY TRANSFER AGENCIES IN INDIA • The major agencies involved in Technology Transfer (TT) in India are: 1. APCTT (Asian and Pacific Centre for Transfer of Technology) 2. NRDC (National Research Development Corporation) 3. TIFAC (Technology Information, Forecasting and Assessment Council) 4. BCIL (Biotech Consortium India Limited) 5. TBSE–SIDBI (Technology Bureau for Small Enterprises) (Small Industries Development Bank of India)
1. APCTT (Asian and Pacific Centre for Transfer of Technology) • Established in 1977 at Bangalore, later shifted to New Delhi in 1993. • A regional institution of UN-ESCAP (United Nations Economic and Social Commission for Asia and the Pacific). • Works with Asia-Pacific countries to promote sustainable technology transfer and innovation. ✓ Functions • Facilitates transfer of environment-friendly technologies. • Provides policy advice to governments for technology adoption. • Promotes South-South cooperation among developing countries. • Organizes training programmes, exhibitions, and workshops. • Builds capacity of SMEs (Small, medium enterprises), research institutes, and startups in the Asia-Pacific region.
2. NRDC (National Research Development Corporation) • Established in 1953 by the Government of India. • Headquartered in New Delhi. • Acts as a bridge between R&D institutions, universities, and industries. • Main aim is to commercialize indigenous technologies. ✓ Functions • Provides patenting and Intellectual Property (IP) protection for inventions. • Licenses technologies from R&D laboratories to industries. • Offers consultancy and advisory services on technology transfer. • Supports startups and SMEs with affordable technology. • Has licensed over 4,500 technologies in fields such as drugs, vaccines, agro-products, and engineering.
3. TIFAC (Technology Information, Forecasting and Assessment Council) • Established in 1988 as an autonomous body under the Department of Science and Technology (DST). • Acts as a national think tank for technology forecasting and planning. • Known for preparing Technology Vision. ✓ Functions • Forecasts future technology needs of the nation. • Prepares long-term technology vision documents. • Facilitates collaboration between industry, academia, and government. • Operates Ekaswa (patent search facility) and other innovation support programmes. • Promotes research in energy, healthcare, environment, agriculture, and rural development.
4. BCIL (Biotech Consortium India Limited) • Established in 1990 as a Public Limited Company. • Promoted by the Department of Biotechnology (DBT), Government of India. • Supported by financial institutions and industry bodies. • Main focus is on biotechnology commercialization and biosafety awareness. ✓ Functions • Facilitates technology transfer and project consultancy in biotechnology. • Provides financial linkages and venture capital support to biotech startups. • Organizes biosafety training and awareness programmes. • Implements DBT flagship schemes such as SBIRI and biotech industrial training programmes. • Supports commercialization of biotech products such as vaccines, diagnostics, enzymes, and genetically modified crops
5. TBSE – SIDBI • TBSE stands for Technology Bureau for Small Enterprises. • SIDBI stands for Small Industries Development Bank of India. • It is a joint initiative of SIDBI and APCTT. • Specially designed to support MSMEs (Micro, Small and Medium Enterprises). • Helps small businesses adopt modern technologies and remain competitive. ✓ Functions • Provides information on domestic and international technologies. • Assists in technology partner search and business collaboration. • Helps MSMEs in project appraisal, business plan preparation, and financial support. • Facilitates import and adaptation of global technologies for Indian industries. • Promotes technology-based entrepreneurship in small enterprises.
❑TECHNOLOGY TRANSFER RELATED DOCUMENTATION • Technology Transfer (TT) in the pharmaceutical industry involves moving a product or process from R&D (Research and Development) to Production (Manufacturing). • Proper documentation is essential to ensure transparency, accountability, and legal compliance. 1) Confidentially Agreement (non-disclosure Agreement – NDA) • A legal document signed b/w two parties (e.g., R&D team and manufacturing site). • Ensures that sensitive information (formulation details, process, test methods) is not shared with unauthorized persons. • Protect intellectual property (IP).
2) Licensing Agreement • A contract where the owner of technology (licensor) gives permission to another party (licensee) to use the technology. • Common in cases where pharmaceutical companies outsource manufacturing or allow other firms to market their products. • Includes terms like royalty, duration, territory, and responsibilities. 3) Memorandum Of Understanding (MOU) • A formal but less legally binding agreement b/w two parties before signing a full contract. • Defines the intent of collaboration, such as knowledge sharing, transfer of data, or training. • Acts as a roadmap for future legal agreements.
4) Legal Issues In TT • Technology transfer may face multiple legal challenges, such as: • Intellectual Property Rights (IPR): Patents, Trademarks, Copyrights. • Regulatory Compliance: Must follow national and international guidelines (FDA, EMA, CDSCO). • Liability Issues: Who is responsible in case of product failure or adverse effects. • Dispute Resolution: Arbitration, legal jurisdiction in case of conflicts.